Brief: Novan Reports Q3 2022 Financial Results

NVN Liquidation

14/11/2022 13:20

Nov 14 (Reuters) - Novan Inc  NOVN.O :
    * NOVAN REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES
CORPORATE UPDATE
    * CONTINUED PROGRESS TOWARD SUBMISSION OF BERDAZIMER GEL,
10.3%
(SB206) NEW DRUG APPLICATION (NDA), TARGETED AROUND END OF 2022
    * QTRLY  LOSS PER SHARE $0.25
    * Q3 EARNINGS PER SHARE VIEW $-0.39 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXqknSQ 
Further company coverage:  NOVN.O 
 ((Reuters.Briefs@thomsonreuters.com;))